Stocktoria

Biofrontera Inc. BFRI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-10-14 · LEI

Biofrontera Inc. statistics & valuation

Market cap$12.4M
P / S0.3×
P / B1.2×
Net margin-25.3%
Return on equity-100.5%
FCF margin-32.0%
Return on capital-68.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-58.30% -156.50% -2.20% -59.10% -47.60% -25.30% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-51.00% -104.60% -64.80% -66.60% -46.10% -27.20% 202020212022202320242025
Return on equity (%)
-188.50% -332.60% -2.70% -420.00% -400.60% -100.50% 202020212022202320242025
Shares outstanding
8.0M 17.1M 1.3M 1.5M 8.9M 11.6M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-45.50% -70.90% -1.30% -72.10% -80.40% -36.90% 202020212022202320242025
Free cash flow margin (%)
-56.60% -73.10% -27.50% -32.00% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$0.61 -$13.02 -$3.22 -$1.04 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-27.2%-46.1%-66.6%-64.8%-104.6%-51.0%
Net margin-25.3%-47.6%-59.1%-2.2%-156.5%-58.3%
FCF margin-32.0%-27.5%-73.1%-56.6%——
Return on assets-36.9%-80.4%-72.1%-1.3%-70.9%-45.5%
Return on equity-100.5%-400.6%-420.0%-2.7%-332.6%-188.5%
Current ratio1.521.721.282.063.364.43

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.